semaglutide trevogrumab and garetosmab and COURAGE Trial confirms potential to improve the quality of semaglutide-induced weight loss by preserving lean mass Are myostatin inhibitors the end – The impact of weight loss

doi: 10.1016/j.jhin.2011.09.003 311 KhodaiiZAfrasiabiSHashemiSAArdeshirylajimiANatanziMM

Typically, telogen effluvium is a temporary condition, and the hair resumes normal growth cycles once the stress has been resolved

Clinical response varies widely, and the optimal dose is the lowest dose that produces the desired effect with acceptable tolerability

In the first month, many patients notice changes in hunger, fullness, and portion control before they see major changes on the scale

Proton pump inhibitors effectively reduce symptoms by decreasing acid production, but symptoms typically return upon discontinuation